Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sodium selenite and Se-enriched yeast supplementation in atherosclerotic patients: Effects on the expression of pyroptosis-related genes and oxidative stress status.
Roshanravan N, Koche Ghazi MK, Ghaffari S, Naemi M, Alamdari NM, Shabestari AN, Mosharkesh E, Soleimanzadeh H, Sadeghi MT, Alipour S, Bastani S, Tarighat-Esfanjani A. Roshanravan N, et al. Among authors: naemi m. Nutr Metab Cardiovasc Dis. 2022 Jun;32(6):1528-1537. doi: 10.1016/j.numecd.2022.02.014. Epub 2022 Mar 7. Nutr Metab Cardiovasc Dis. 2022. PMID: 35365371 Clinical Trial.
Oleoylethanolamide supplementation in obese patients newly diagnosed with non-alcoholic fatty liver disease: Effects on metabolic parameters, anthropometric indices, and expression of PPAR-α, UCP1, and UCP2 genes.
Tutunchi H, Ostadrahimi A, Saghafi-Asl M, Hosseinzadeh-Attar MJ, Shakeri A, Asghari-Jafarabadi M, Roshanravan N, Farrin N, Naemi M, Hasankhani M. Tutunchi H, et al. Among authors: naemi m. Pharmacol Res. 2020 Jun;156:104770. doi: 10.1016/j.phrs.2020.104770. Epub 2020 Mar 23. Pharmacol Res. 2020. PMID: 32217148 Clinical Trial.
Effects of sodium selenite and selenium-enriched yeast on cardiometabolic indices of patients with atherosclerosis: A double-blind randomized clinical trial study.
Khabbaz Koche Ghazi M, Ghaffari S, Naemi M, Salehi R, Taban Sadeghi M, Barati M, Namazi Shabestari A, Kafil B, Mesri Alamdari N, Soleimanzadeh H, Tarighat-Esfanjani A, Roshanravan N. Khabbaz Koche Ghazi M, et al. Among authors: naemi m. J Cardiovasc Thorac Res. 2021;13(4):314-319. doi: 10.34172/jcvtr.2021.51. Epub 2021 Dec 5. J Cardiovasc Thorac Res. 2021. PMID: 35047136 Free PMC article.
Prevalence, awareness and risk factors of hypertension in a large cohort of Iranian adult population.
Malekzadeh MM, Etemadi A, Kamangar F, Khademi H, Golozar A, Islami F, Pourshams A, Poustchi H, Navabakhsh B, Naemi M, Pharoah PD, Abnet CC, Brennan P, Boffetta P, Dawsey SM, Esteghamati A, Malekzadeh R. Malekzadeh MM, et al. Among authors: naemi m. J Hypertens. 2013 Jul;31(7):1364-71; discussion 1371. doi: 10.1097/HJH.0b013e3283613053. J Hypertens. 2013. PMID: 23673348 Free PMC article.
Polypill for the prevention of cardiovascular disease (PolyIran): study design and rationale for a pragmatic cluster randomized controlled trial.
Ostovaneh MR, Poustchi H, Hemming K, Marjani H, Pourshams A, Nateghi A, Majed M, Navabakhsh B, Khoshnia M, Jaafari E, Mohammadifard N, Malekzadeh F, Merat S, Sadeghi M, Naemi M, Etemadi A, Thomas GN, Sarrafzadegan N, Cheng KK, Marshall T, Malekzadeh R. Ostovaneh MR, et al. Among authors: naemi m. Eur J Prev Cardiol. 2015 Dec;22(12):1609-17. doi: 10.1177/2047487314550803. Epub 2014 Sep 17. Eur J Prev Cardiol. 2015. PMID: 25230980 Free PMC article. Clinical Trial.
23 results